Publication List 2016

1984-94, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018

11
(434)
Sakurai T, Isogaya K, Sakai S, Morikawa M, Morishita Y, Ehata S, Miyazono K, Koinuma D.
RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.
Oncogene. 2016 Sep 22;35(38):5000-9.
10
(433)
Vasilaki E, Morikawa M, Koinuma D, Mizutani A, Hirano Y, Ehata S, Sundqvist A, Kawasaki N, Cedervall J, Olsson AK, Aburatani H, Moustakas A, Miyazono K, Heldin CH
Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program.
Sci Signal. 2016 Aug 23;9(442):ra84.
9
(432)
Mizutani A, Koinuma D, Seimiya H, Miyazono K.
The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.
Oncogene. 2016 Jul 7;35(27):3514-23.
8
(431)
Morikawa M, Derynck R, Miyazono K.
TGF-β and the TGF-β family: context-dependent roles in cell and tissue physiology.
Cold Spring Harb Perspect Biol. 2016 May 2;8(5). pii:a021873.
7
(430)
Sakai S, Iwata C, Tanaka HY, Cabral H, Morishita Y, Miyazono K, Kano MR.
Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2.
J Control Release. 2016 May 28;230:109-15.
6
(429)
Morikawa M, Koinuma D, Mizutani A, Kawasaki N, Holmborn K, Sundqvist A, Tsutsumi S, Watabe T, Aburatani H, Heldin CH, Miyazono K.
BMP sustains embryonic stem cell self-renewal through distinct functions of different Krüppel-like factors.
Stem Cell Reports. 2016 Jan 12;6(1):64-73.
5
(428)
Katsura A, Suzuki HI, Ueno T, Mihira H, Yamazaki T, Yasuda T, Watabe T, Mano H, Yamada Y, Miyazono K.
MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-β.
Genes Cells. 2016 Jan;21(1):99-116.
4
(427)
Kaneda A, Nonaka A, Fujita T, Yamanaka R, Fujimoto M, Miyazono K, Aburatani H.
Epigenomic regulation of Smad1 signaling during cellular senescence induced by Ras activation.
Methods Mol Biol. 2016;1344:341-53.
3
(426)
Hosoya H, Dobroff AS, Driessen WH, Cristini V, Brinker LM, Staquicini FI, Cardó-Vila M, D'Angelo S, Ferrara F, Proneth B, Lin YS, Dunphy DR, Dogra P, Melancon MP, Stafford RJ, Miyazono K, Gelovani JG, Kataoka K, Brinker CJ, Sidman RL, Arap W, Pasqualini R.
Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release.
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1877-82.
2
(425)
Davis H, Raja E, Miyazono K, Tsubakihara Y, Moustakas A.
Mechanisms of action of bone morphogenetic proteins in cancer.
Cytokine Growth Factor Rev. 2016 Feb;27:81-92.
1
(424)
Ando M, Kawazu M, Ueno T, Koinuma D, Ando K, Koya J, Kataoka K, Yasuda T, Yamaguchi H, Fukumura K, Yamato A, Soda M, Sai E, Yamashita Y, Asakage T, Miyazaki Y, Kurokawa M, Miyazono K, Nimer SD, Yamasoba T, Mano H.
Mutational landscape and antiproliferative functions of ELF transcription factors in human cancer.
Cancer Res. 2016 Apr 1;76(7):1814-24.